Mary P. McGowan
2017
In 2017, Mary P. McGowan earned a total compensation of $3.1M as Chief Medical Officer at Esperion Therapeutics, a 349% increase compared to previous year.
Compensation breakdown
| Option Awards | $2,691,209 |
|---|---|
| Salary | $395,000 |
| Other | $12,000 |
| Total | $3,098,209 |
McGowan received $2.7M in option awards, accounting for 87% of the total pay in 2017.
McGowan also received $395K in salary and $12K in other compensation.
Rankings
In 2017, Mary P. McGowan's compensation ranked 3,500th out of 14,666 executives tracked by ExecPay. In other words, McGowan earned more than 76.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,500 out of 14,666 | 76th |
Division Manufacturing | 1,214 out of 5,770 | 79th |
Major group Chemicals And Allied Products | 334 out of 2,074 | 84th |
Industry group Drugs | 256 out of 1,730 | 85th |
Industry Pharmaceutical Preparations | 204 out of 1,329 | 85th |
Source: SEC filing on April 13, 2018.
McGowan's colleagues
We found two more compensation records of executives who worked with Mary P. McGowan at Esperion Therapeutics in 2017.